SEED Co.,Ltd.

Tokyo Stock Exchange 7743.T

SEED Co.,Ltd. EPS (Diluted) for the year ending March 31, 2024: USD 0.51

SEED Co.,Ltd. EPS (Diluted) is USD 0.51 for the year ending March 31, 2024, a 637.92% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

SEED Co.,Ltd. EPS (Diluted) for the year ending March 31, 2023 was USD -0.10, a -125.11% change year over year.
SEED Co.,Ltd. EPS (Diluted) for the year ending March 31, 2022 was USD 0.38, a -7.09% change year over year.
SEED Co.,Ltd. EPS (Diluted) for the year ending March 31, 2021 was USD 0.41, a 333.91% change year over year.
SEED Co.,Ltd. EPS (Diluted) for the year ending March 31, 2020 was USD 0.09, a -72.95% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

Tokyo Stock Exchange: 7743.T

SEED Co.,Ltd.

CEO	Mr. Masahiro Urakabe
IPO Date	Jan. 4, 2000
Location	Japan
Headquarters	2-40-2 Hongo
Employees	962
Sector	Consumer Discretionary
Industries Eyewear Cosmetics

Description

SEED Co.,Ltd. manufactures and supplies contact lenses, care products, spectacle frames, and other eye care products in Japan and internationally. The company offers SEED 1dayPure moisture daily disposable, SEED 1dayPure moisture multistage, SEED Eye coffret 1day UV, SEED 1dayPure EDOF, SEED PlusMode 1day Homme, and JILL STUART 1day UV contact lenses, as well as SEED 1dayPure moisture contact lenses for astigmatism. It also provides SEED 2weekPure moisture disposable contact lenses and SEED 2weekPure moisture multistage bifocal lenses, as well as SEED 2weekPure moisture contact lenses for astigmatism; SEED MonthlyFine UV and monthly color lens UV replacement contact lenses; rigid gas permeable contact lenses; and medical contact lenses. In addition, the company offers glass frames under the Vivid Moon, ViVi fleurs, and Plusmix brand names; and pharmaceutical products, such as Adeno Test AD, an adenovirus antigen detection agent, and other products for better vision. SEED Co., Ltd. was founded in 1957 and is headquartered in Tokyo, Japan.

Key trends

Past 5 years